Altered binding of chloroquine to ferriprotoporphyrin IX is the basis for chloroquine resistance

Drug Resistance Updates

Volumn 2, Issue 2, 1999, Pages 97-103

  Raynes, Kaylene J ^a   Bray, Patrick G ^a   Ward, Stephen A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; CHLOROQUINE; HEMATIN; HYDROGEN; SODIUM; VERAPAMIL;

ANTIBIOTIC RESISTANCE; ANTIMALARIAL ACTIVITY; CELL PH; DRUG ACCUMULATION; DRUG BINDING; DRUG SPECIFICITY; DRUG TRANSPORT; DRUG UPTAKE; ION EXCHANGE; MOLECULAR MODEL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW;

EID: 0032982002     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.1999.0077     Document Type: Article

References (51)

1. Ferrari V., Cutler D. J. Simulation of kinetic data on the influx of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for a drug-importor in chloroquine senstive strains. Biochem Pharmacol. 42:1991;69-79.
2. Krogstad D. J., Sclesinger P. H., Gluzman L. Y. Antimalarials increase vesicle pH in Plasmodium falciparum. J Cell Biol. 101:1985;2302-2309.
3. Yayon A., Cabantchik Z., Ginsburg H. Identification of the acidic compartment of Plasmodium falciparum infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 3:1984;2695-2700.
4. Ginsburg H., Nissani E., Krugliak M. Alkanisation of the food vacuole of malaria parasites by quinoline drugs and alkyl amines is not correlated with their antimalarial activity. Biochem Pharmacol. 38:1989;2645-2654.
5. Homewood C. A., Warhurst D. C., Peters W. Lysosomes, pH and the antimalarial action of chloroquine. Nature. 235:1972;50-52.
6. Geary T. G., Jensen J. B., Ginsburg H. Uptake of H3 chloroquine by drug sensitive and resistant strains of the human malarial parasite Plasmodium falciparum. Biochem Pharmacol. 35:1986;3805-3812.
7. Geary T. G., Divo A. D., Jensen J. Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. Biochem Pharmacol. 40:1990;685-691.
8. Ginsburg H., Stein W. D. Kinetic modelling of chloroquine uptake by malaria infected erythrocytes. Assessment of the factors that may affect drug resistance. Biochem Pharmacol. 41:1991;1463-1470.
9. Bray P. G., Howells R. E., Ward S. A. Vacuolar acidification and CQ sensitivity in Plasmodium falciparum. Biochem Pharmacol. 43:1992;1219-1227.
10. De Duve C., De Barsy T., Poole B. Lysosomotrophic agents. Biochem Pharmacol. 69:1974;2495-2531.
11. Krogstad D. J., Gluzman I. Y., Herwaldt B. L. Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. Biochem Pharmacol. 43:1992;57-62.
12. MacIntryre A. C., Cutler D. J. In vivo binding of chloroquine to rat muscle preparations. J Pharm Sci. 75:1986;1068-1070.
13. Hawley S. R., Bray P. G., O'Neill P. M. The role of drug accumulation in 4-aminoquinoline antimalarial potency. Biochem Pharmacol. 52:1996;723-733.
14. Yayon A., Cabantchik Z. I., Ginsburg H. Susceptibility of human malaria paprasites to chloroquine is pH dependent. Proc Natl Acad Sci USA. 82:1985;2784-2788.
15. Bray P. G., Boulter M. K., Ritchie G. Y. Relationship of global chloroquine transport and reversal of resistance in Plasmodium falciparum. Mol Biochem Parasitol. 63:1994;87-94.
16. Martiney J. A., Cerami A., Slater A. F. G. Verapamil reversal of chloroquine resistance in the malarial parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect. J Biol Chem. 270:1995;22393-22398.
17. Fitch C. D. Plasmodium falciparum in owl monkeys. Drug resistance and chloroquine binding capacity. Science. 169:1970;289-290.
18. Fitch C. D., Yunis N. G., Chevil R. High affinity accumulation of chloroquine by mouse erythrocytes infected with Plasmodium Berghi. J Clin Invest. 54:1974;24-33.
19. Fitch C. D. Malaria and the red cell. 2nd ed. 1989;Alan R Liss, New York.
20. Bray P. G., Mungthin M., Ridley R. Access to hematin: The basis of chloroquine resistance. Mol Pharmacol. 54:1998;170-179.
21. Bray P. G., Hawley S. R., Ward S. A. 4-Aminoquinoline resistance of Plasmodium falciparum: Insights from the study of amodiaquine uptake. Mol Pharmacol. 50:1996;1551-1558.
22. Warhurst D. C. Antimalarial schizontocides: Why a permease is necessary. Parasitol Today. 4:1986;211-213.
23. Bray P. G., Howells R. E., Ritchie G. Y. Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine resistant Plasmodium falciparum: correlation of chloroquine sensitivity with energy dependent drug accumulation. Biochem Pharmacol. 44:1992;1317-1324.
24. Bray P. G., Hawley S. R., Mungthin M. Physiochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Mol Pharmacol. 50:1996;1559-1566.
25. Sanchez C. P., Wünsch S., Lanzer M. Identification of a chloroquine importer in Plasmodium falciparum: differences in import kinetics are genetically linked with the chloroquine resistance phenotype. J Biol Chem. 272:1997;2652-2658.
26. Wünsch S., Sanchez C. P., Gekle M. Differential stimulation of the Na+/H+ exchanger determines chloroquine uptake in Plasmodium falciparum. J Cell Biol. 140:1998;335-345.
27. Martin S. K., Odula A. M., Milhous W. K. Reversal of chloroquine resistance by verapamil. Science. 235:1987;899-901.
28. Krogstad D. J., Schlesinger P. H. The basis for antimalarial action: non-weak base effects of chloroquine on acid vesicle pH. Am J Trop Med Hyg. 36:1987;213-220.
29. Wellems T. E., Panton L. T., Gluzman I. Y. Chloroquine resistance not linked to the mdr-like genes in Plasmodium falciparum. Nature. 345:1990;253-255.
30. Walter R. D., Seth M., Bhaduri A. P. Reversal of chloroquine resistance in Plasmodium falciparum by cdr-87/209 and analogs. Trop Med Parasitol. 44:1993;5-8.
31. Su X. Z., Kirkman L. A., Fujioka H. Complex polymorphisms in a 330kDa protein is linked to chloroquine resistance in Plasmodium falciparum in Southeast Asia and Africa. Cell. 91:1997;593-603.
32. Ye Z. G., Van Dyke K. Reversal of chloroquine resistance in Falciparum-malaria independent of calcium channels. Biochem Biophys Res Commun. 155:1988;476-481.
33. Gottesman M. M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 62:1993;385-427.
34. Bray P. G., Ward S. A. A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance inPlasmodium falciparum. Pharmacol Ther. 77:1998;1-28.
35. Bray P. G., Jennah O., Raynes K. J., Mungthin M. Cellular uptake of chloroquine is dependent on hematin and independent of NHE activity in Plasmodium falciparum. J Cell Biol. 145:1999;363-376.
36. Bayoumi R. A., Babiker H. A., Arnot D. E. Uptake and efflux of chloroquine by chloroquine-resistant Plasmodium falciparum clones recently isolated in Africa. Acta Trop. 58:1994;141-149.
37. De D., Krogstad F. M., Cogswell F. B. Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am J Trop Med Hyg. 55:1996;579-583.
38. Ridley R. G., Hofheinz H., Matile C. 4-Aminoquinoline analogs of chloroquine with shortened sidechains retain activity against chloroquine resistantPlasmodium falciparum. Antimicrob Agents Chemother. 40:1996;1846-1854.
39. Chou A., Fitch C. D. Control of Heme polymerase by chloroquine and other quinoline derivatives. Biochem Biophys Res Commun. 195:1993;422-427.
40. Francis S. E., Sullivan D. J., Goldberg D. E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Biochem. 51:1997;97-123.
41. Chou A. C., Chevli R., Fitch C. D. Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry. 19:1980;1543-1549.
42. Warhurst D. C. The quinine-haemin interaction and its relationship to antimalarial activity. Biochem Pharmacol. 30:1981;3323-3327.
43. Macomber P. B., Sprinz H., Tousimis A. J. Morphological effects of chloroquine on Plasmodium berghei in mice. Nature. 214:1967;937-939.
44. Fitch C. D. Chloroquine resistance in malaria: a deficiency of chloroquine binding. Proc Natl Acad Sci USA. 64:1969;1181-1187.
45. Ginsburg H., Geary T. Current concepts and new ideas on the mechanism of action of quinoline containing antimalarials. Biochem Pharmacol. 36:1987;1567-1576.
46. Goldberg D. E., Slater A. F. G., Cerami A. Haemoglobin degradation in malaaria parsite Plasmodium falciparum. An ordered process in a unique organelle. Proc Natl Acad Sci USA. 87:1990;2931-2935.
47. Moon R. P., Tyas L., Certa U. Expression and characterisation of Plasmepsin I from Plasmodium falciparum. Eur J Biochem. 244:1997;552-560.
48. Mungthin M., Bray P., Ridley R. The centrol role of hemoglobin degradation in the mechanism of action of 4-aminoquinolines, the quinoline methanols and phenanthrene methanols. Antimicrob Agents Chemother. 42:1998;2973-2984.
49. Slomianny C., Prensier G., Charet P. Ingestion of erythrocytic stroma by Plasmodium chabaudi trophozoites: Ultrastructural study by serial sectioning and 3D reconstruction. Parasitol. 90:1985;579-588.
50. Slomianny C., Prensier G. Cytochemical ultrstructural study of the lysosomal system of different species of malaria parasites. J Protozool. 37:1990;465-470.
51. Ward G., Tilney L., Rab G. Pases and the unusual secretory pathway of Plasmodia. Parasitol Today. 13:1997;57-62.